identifier	patientIdentifier	gene	rnaExpression	imputedGeneExpression	dnaVariantAlleleFrequency	rnaVariantAlleleFrequency	mutation.position	mutation.wildTypeXmer	mutation.mutatedXmer
wYBDef9fZS4ezOUY7n3FtA==	26284bc3-3c5b-41aa-90d0-b966fd1000db	BRCA2	15.78	0.0	0.352	0.738	14	RDGRKGEASQHPTAGGCVCDPQGVLYL	RDGRKGEASQHPTPGGCVCDPQGVLYL
fq0TbavNm9K26nWp+rNBLA==	26284bc3-3c5b-41aa-90d0-b966fd1000db	BRCA2	14.26	0.0	0.852	0.191	14	LLWAGPVNAGVTQTPKFRVLKTGQSMT	LLWAGPVNAGVTQFPKFRVLKTGQSMT
qsdNCIRfhTGEH/KcVQFMjw==	26284bc3-3c5b-41aa-90d0-b966fd1000db	BRCA2	23.76	0.0	0.755	0.296	14	PENNMAANIDCAGILKLRNSDIELRKG	PENNMAANIDCAGRLKLRNSDIELRKG
B1+W2Z9Z7a4iUWWA0oGAaw==	26284bc3-3c5b-41aa-90d0-b966fd1000db	BRCA2	78.03	0.0	0.943	0.563	14	MGECRSSLSAGGGVHIEPRYRQFPQLT	MGECRSSLSAGGGWHIEPRYRQFPQLT
ovndK4P91hc6VEK0D5IQMA==	26284bc3-3c5b-41aa-90d0-b966fd1000db	BRCA2	96.4	0.0	0.831	0.183	14	YVSFKQYVGKHILFVNVATYCGLTAQY	YVSFKQYVGKHILKVNVATYCGLTAQY
GfmM+AKX/2Fr/Zbu8beK8w==	26284bc3-3c5b-41aa-90d0-b966fd1000db	BRCA2	39.35	0.0	0.208	0.33	14	GATLIRDRLKTEPFEENSFLEQFMIEK	GATLIRDRLKTEPCEENSFLEQFMIEK
29RpiIad6TMvHaQpcinDTg==	26284bc3-3c5b-41aa-90d0-b966fd1000db	BRCA2	52.69	0.0	0.15	0.103	14	ATNLQEIRNGFSEIRGSVQAKDGNIDI	ATNLQEIRNGFSEARGSVQAKDGNIDI
JN322OZFd75hjDiSXBOFuA==	26284bc3-3c5b-41aa-90d0-b966fd1000db	BRCA2	56.07	0.0	0.711	0.174	14	GWMTSVKDWAGVMISAQTLTGRVLVVL	GWMTSVKDWAGVMRSAQTLTGRVLVVL
R3EU9H6eab9hdTxuo5kBew==	26284bc3-3c5b-41aa-90d0-b966fd1000db	BRCA2	14.69	0.0	0.997	0.356	14	FRYFRELFGIRPDDYLYSLCSEPLIEL	FRYFRELFGIRPDQYLYSLCSEPLIEL
1l+MKRwT0gR3zU7k+LrtCg==	26284bc3-3c5b-41aa-90d0-b966fd1000db	BRCA2	11.86	0.0	0.655	0.625	14	SSLLYGSIPKAAVRFGMFEFLSNHMRD	SSLLYGSIPKAAVNFGMFEFLSNHMRD
4XGS9xe4kFm8bXGIl+hgWg==	a4e661cb-867f-4f4a-b851-ae3ed2dd22d9	BRCA2	88.66	0.0	0.137	0.389	14	QPSTCVFSSCNTTCCVPSHCQPPHCQL	QPSTCVFSSCNTTTCVPSHCQPPHCQL
S0E4TH12GlQvDfFmV7nSQg==	a4e661cb-867f-4f4a-b851-ae3ed2dd22d9	BRCA2	74.75	0.0	0.69	0.569	14	MAPEVLPKPRMRGLLARRLRNHMAVAF	MAPEVLPKPRMRGMLARRLRNHMAVAF
CU1biJ/VZagLC1JPliWUig==	a4e661cb-867f-4f4a-b851-ae3ed2dd22d9	BRCA2	11.85	0.0	0.273	0.603	14	QQLLKRGFVLQDTVEQLRCEHCARFLA	QQLLKRGFVLQDTWEQLRCEHCARFLA
dh1pukwJwgJxM4OxlS9ArA==	a4e661cb-867f-4f4a-b851-ae3ed2dd22d9	BRCA2	15.43	0.0	0.986	0.957	14	IELHLFMLNGLPDNVFELTEMEVLSLE	IELHLFMLNGLPDTVFELTEMEVLSLE
SaGgEuSEMG08YvWAj63JzA==	a4e661cb-867f-4f4a-b851-ae3ed2dd22d9	BRCA2	74.86	0.0	0.491	0.387	14	RIKLGFTQGDVGLAMGKLYGNDFSQTT	RIKLGFTQGDVGLTMGKLYGNDFSQTT
deTff878epblq5/bQchNew==	a4e661cb-867f-4f4a-b851-ae3ed2dd22d9	BRCA2	75.97	0.0	0.752	0.904	14	RIATDPTIHTVPEGRPVNVCVGKEWYR	RIATDPTIHTVPETRPVNVCVGKEWYR
oDlnfMVJngJiXPsUUOwJbA==	a4e661cb-867f-4f4a-b851-ae3ed2dd22d9	BRCA2	40.42	0.0	0.37	0.816	14	DAEWYWGDISREEVNDKLRDMPDGTFL	DAEWYWGDISREERNDKLRDMPDGTFL
lE/NC70auYYy1F+IYBcpqg==	a4e661cb-867f-4f4a-b851-ae3ed2dd22d9	BRCA2	90.95	0.0	0.13	0.498	14	AAEISIGLFFLHKRGIIYRDLKLDNVM	AAEISIGLFFLHKMGIIYRDLKLDNVM
N/tlLtSedL6nVloU7/Ghsg==	a4e661cb-867f-4f4a-b851-ae3ed2dd22d9	BRCA2	48.74	0.0	0.625	0.377	14	DSHDSHLMPSPAPVAQPLPGHVVPCPS	DSHDSHLMPSPAPDAQPLPGHVVPCPS
x5eYZwlcXphdN7ohyksRZw==	a4e661cb-867f-4f4a-b851-ae3ed2dd22d9	BRCA2	58.17	0.0	0.78	0.673	14	GGDTISKMPDVKESVPPKYPGDSEGRS	GGDTISKMPDVKEVVPPKYPGDSEGRS
x+fdx1FBXZ5eiuDkotYjPQ==	c32cd702-e86d-40e3-b1ba-199cbedd09cd	BRCA2	91.64	0.0	0.496	0.51	14	LDGTLKGKNGAVYPKHSGFCLETQNWP	LDGTLKGKNGAVYSKHSGFCLETQNWP
OmOTpfoiSdepbo5HYVw6kA==	c32cd702-e86d-40e3-b1ba-199cbedd09cd	BRCA2	54.43	0.0	0.895	0.305	14	EEHSRWRDRSRTRSRSRTPFRLSEKDR	EEHSRWRDRSRTRKRSRTPFRLSEKDR
ef+b8gHSyhUrcOD2HHYDsA==	c32cd702-e86d-40e3-b1ba-199cbedd09cd	BRCA2	25.17	0.0	0.621	0.807	14	VKLSIVLTPQFLSHDQGQLTKELQQHV	VKLSIVLTPQFLSQDQGQLTKELQQHV
ZEmRH8PfszXF9DtBOPm68Q==	c32cd702-e86d-40e3-b1ba-199cbedd09cd	BRCA2	41.42	0.0	0.188	0.392	14	LQQERRFLMRVLDSYGDDYRASQFTIV	LQQERRFLMRVLDLYGDDYRASQFTIV
Xe0jnSZsYimmOYHp0ACUDg==	c32cd702-e86d-40e3-b1ba-199cbedd09cd	BRCA2	73.07	0.0	0.786	0.971	14	LAGVIFIDRKRTGDAISVMSEVAQTLL	LAGVIFIDRKRTGYAISVMSEVAQTLL
L4Vh781HprCmG35K3gXHuw==	c32cd702-e86d-40e3-b1ba-199cbedd09cd	BRCA2	37.94	0.0	0.318	0.829	14	LVTYASLLLVLALLLRLCRQPLHLHSL	LVTYASLLLVLALCLRLCRQPLHLHSL
fPizrNvcI/Jxbp+vpiF8ZA==	c32cd702-e86d-40e3-b1ba-199cbedd09cd	BRCA2	86.41	0.0	0.144	0.485	14	KAGVNYTMQVYPDEGHNVSEKSKYHLY	KAGVNYTMQVYPDQGHNVSEKSKYHLY
TNxlFjuOeQPVVz+vg2FUpA==	c32cd702-e86d-40e3-b1ba-199cbedd09cd	BRCA2	40.05	0.0	0.365	0.31	14	VAEGIKIGIQECQHQFRGRRWNCTTVH	VAEGIKIGIQECQYQFRGRRWNCTTVH
wM042ZkBFeTKs+inCKLBMw==	c32cd702-e86d-40e3-b1ba-199cbedd09cd	BRCA2	35.61	0.0	0.964	0.971	14	EPHKKGDGNSSVPGSMEGRAGLSRTVP	EPHKKGDGNSSVPRSMEGRAGLSRTVP
G2GjA+WWaGUUAh2mX5bMrw==	c32cd702-e86d-40e3-b1ba-199cbedd09cd	BRCA2	59.28	0.0	0.24	0.376	14	LAVYLELQNGNTQLALQIIKRNQLLPA	LAVYLELQNGNTQWALQIIKRNQLLPA
gAm4SFskQz+kv4nuEwl7qA==	7763fd2d-eae9-4e7c-88ca-490df022a35a	BRCA2	32.94	0.0	0.684	0.799	14	RALETLTGALFQRPPLIAAVKRQLRVR	RALETLTGALFQRTPLIAAVKRQLRVR
9G0LYc/hd3vBKhbnZm20TA==	7763fd2d-eae9-4e7c-88ca-490df022a35a	BRCA2	93.84	0.0	0.414	0.903	14	LFLELVPAYNHLLEKAELLDKFSKKLQ	LFLELVPAYNHLLDKAELLDKFSKKLQ
4cD/9ILGS6Wth9uym85nyw==	7763fd2d-eae9-4e7c-88ca-490df022a35a	BRCA2	18.01	0.0	0.266	0.428	14	LVREIAQDFKTDLRFQSSAVMALQEAS	LVREIAQDFKTDLSFQSSAVMALQEAS
33x1WaGT6HvNQKdZ+czSzw==	7763fd2d-eae9-4e7c-88ca-490df022a35a	BRCA2	28.28	0.0	0.215	0.291	14	PRCELPVGAGSHDALIVGKFYEVFAEE	PRCELPVGAGSHDNLIVGKFYEVFAEE
/VmEa6FWPbDDapvBBAZs4w==	7763fd2d-eae9-4e7c-88ca-490df022a35a	BRCA2	27.77	0.0	0.151	0.68	14	LLDALTTDMVQAINSAAPTGGGRFSEP	LLDALTTDMVQAIESAAPTGGGRFSEP
JVUxRfw+fD5hK/qs6I/bxA==	7763fd2d-eae9-4e7c-88ca-490df022a35a	BRCA2	65.09	0.0	0.101	0.543	14	ESLSVQTRKKKGDKDEGPSRCSAAPEP	ESLSVQTRKKKGDHDEGPSRCSAAPEP
uviuz6lViVH3hbjQO55G4A==	7763fd2d-eae9-4e7c-88ca-490df022a35a	BRCA2	83.94	0.0	0.315	0.759	14	FQLHTNVNDGTEFGGSIYQKVNKKLET	FQLHTNVNDGTEFKGSIYQKVNKKLET
+kWS0cxu02HbWpiqjpr4Og==	7763fd2d-eae9-4e7c-88ca-490df022a35a	BRCA2	36.85	0.0	0.603	0.619	14	RNVQIEMAHGTTTLAFKFQHGVIAAVD	RNVQIEMAHGTTTIAFKFQHGVIAAVD
/TNsf+1L8c0Er0P/k7a3nQ==	7763fd2d-eae9-4e7c-88ca-490df022a35a	BRCA2	78.71	0.0	0.655	0.589	14	AGVWMIMNAFILLLCEAPFCCQFIEFA	AGVWMIMNAFILLCCEAPFCCQFIEFA
6v0WrkNQErKd0mrDeWvmYQ==	7763fd2d-eae9-4e7c-88ca-490df022a35a	BRCA2	28.88	0.0	0.566	0.841	14	EWFFKKNPFGLVPVLENSQGQLIYESA	EWFFKKNPFGLVPELENSQGQLIYESA
7I90TvC4fmHhtfx7cfym5A==	e8580ba9-8bf9-4f80-979f-7ea7b9221a59	BRCA2	34.47	0.0	0.708	0.581	14	GAALQTLYILAYLHYCPRKAKVIQTKS	GAALQTLYILAYLEYCPRKAKVIQTKS
g2Qx16GHs0SuA/uyo5MPXw==	e8580ba9-8bf9-4f80-979f-7ea7b9221a59	BRCA2	13.81	0.0	0.855	0.188	14	PRERRALFLQATPHQDISRRVAAFRFE	PRERRALFLQATPDQDISRRVAAFRFE
TUCBOw0XT93g59tyFFQntQ==	e8580ba9-8bf9-4f80-979f-7ea7b9221a59	BRCA2	67.95	0.0	0.608	0.413	14	NLKKLLRETQKEVTFPANHTISQECKV	NLKKLLRETQKEVAFPANHTISQECKV
fMhzhOSxyO1Ofdhc5bv9/A==	e8580ba9-8bf9-4f80-979f-7ea7b9221a59	BRCA2	10.51	0.0	0.985	0.507	14	GSAPHSESDLPEQEEEILGSDDDEQED	GSAPHSESDLPEQQEEILGSDDDEQED
7jH3oZYa0tJgah4k93pzGg==	e8580ba9-8bf9-4f80-979f-7ea7b9221a59	BRCA2	91.82	0.0	0.889	0.117	14	PCLLPGTQTPFPMEHHSADPFYFCHGL	PCLLPGTQTPFPMLHHSADPFYFCHGL
jyJ1XV/oneA5xjqm521sxA==	e8580ba9-8bf9-4f80-979f-7ea7b9221a59	BRCA2	63.26	0.0	0.462	0.864	14	LWTVFYRRSQISMEQLEKLQGTLFSTE	LWTVFYRRSQISMDQLEKLQGTLFSTE
2mZ4ZaHco2NRk5/LwtsQnQ==	e8580ba9-8bf9-4f80-979f-7ea7b9221a59	BRCA2	42.69	0.0	0.795	0.613	14	LATAQPLNVGVAHVVRQQQSSSLPSKK	LATAQPLNVGVAHQVRQQQSSSLPSKK
IkLKKhe/2dxV4yhaKuOw2w==	e8580ba9-8bf9-4f80-979f-7ea7b9221a59	BRCA2	26.93	0.0	0.968	0.29	14	ACSHDPLSPDGLSEYYFKMSSRRMRCK	ACSHDPLSPDGLSMYYFKMSSRRMRCK
8+PmlqYF97RrL2rpXuvPMA==	e8580ba9-8bf9-4f80-979f-7ea7b9221a59	BRCA2	43.89	0.0	0.437	0.23	14	HDFRHQILQTRGALSLQGSIMTVGEKV	HDFRHQILQTRGASSLQGSIMTVGEKV
LbV0conCuu6zfodA16vWPg==	e8580ba9-8bf9-4f80-979f-7ea7b9221a59	BRCA2	88.53	0.0	0.445	0.98	14	GAFYRRAQRLRPQDEPRQGCQPEDRRR	GAFYRRAQRLRPQYEPRQGCQPEDRRR
ttKaWewm5of447tGTKnI7Q==	b97b2881-f732-4d30-b124-18d6f4f5ac84	BRCA2	31.54	0.0	0.736	0.922	14	RHLIAGGTVSALCQAYLGHGYGFDQAL	RHLIAGGTVSALCCAYLGHGYGFDQAL
LmEX4eNE68O1jEFcf4L0xQ==	b97b2881-f732-4d30-b124-18d6f4f5ac84	BRCA2	84.16	0.0	0.32	0.541	14	GQYSMADFTGPCPLEIERIKIESLLYR	GQYSMADFTGPCPTEIERIKIESLLYR
oOx5QF9Mn12HzXkzH+3oVw==	b97b2881-f732-4d30-b124-18d6f4f5ac84	BRCA2	84.3	0.0	0.285	0.296	14	APHFLQGLLGLLTPTGELGSKEALWGG	APHFLQGLLGLLTITGELGSKEALWGG
3c8pVy2UZrMZ6KXXuKy/rw==	b97b2881-f732-4d30-b124-18d6f4f5ac84	BRCA2	25.74	0.0	0.127	0.79	14	FEPVFSLFAFTNKITSVHSRIIWSCDW	FEPVFSLFAFTNKLTSVHSRIIWSCDW
zjHoziIX50fJD91rnhRTAQ==	b97b2881-f732-4d30-b124-18d6f4f5ac84	BRCA2	54.7	0.0	0.435	0.833	14	EQNWECLECRGIIYNSGEFQKAKKHVL	EQNWECLECRGIIDNSGEFQKAKKHVL
1lyI8rOtamY9U9+n+Ghqvg==	b97b2881-f732-4d30-b124-18d6f4f5ac84	BRCA2	37.16	0.0	0.603	0.412	14	AMLQRKKNQCIVISGESGSGKTQSTNF	AMLQRKKNQCIVIDGESGSGKTQSTNF
0Z6fp8Y7pnNXEKk1NBbj7w==	b97b2881-f732-4d30-b124-18d6f4f5ac84	BRCA2	68.63	0.0	0.471	0.217	14	AVPEAPTPMWPDDLQNHTFLHTVYCQD	AVPEAPTPMWPDDVQNHTFLHTVYCQD
1ijKQ1W0i4bvUrMdZok0NQ==	b97b2881-f732-4d30-b124-18d6f4f5ac84	BRCA2	13.47	0.0	0.615	0.651	14	LRELCLTQFQVDMEAVGETLWCDWGRT	LRELCLTQFQVDMDAVGETLWCDWGRT
04mhdzhdn5v8uVZtvPmVXg==	b97b2881-f732-4d30-b124-18d6f4f5ac84	BRCA2	39.24	0.0	0.227	0.175	14	GEFYGATECNCSIANMDGKVGSCGFNS	GEFYGATECNCSIGNMDGKVGSCGFNS
3qzeO6w4ixhhNIu0i7se0w==	b97b2881-f732-4d30-b124-18d6f4f5ac84	BRCA2	96.48	0.0	0.955	0.922	14	TQVVWYSSYLVGCGNAYCPNQKVLKYY	TQVVWYSSYLVGCSNAYCPNQKVLKYY
zO3cCIpupS6yBlawc1PoCA==	74033626-4cde-4782-be79-e18d2ac8e0fe	BRCA2	46.48	0.0	0.551	0.638	14	CHSHAFAPERRGHLRPSFHGHHEKGKE	CHSHAFAPERRGHDRPSFHGHHEKGKE
PN55TpiBwU2NsH2w8TDHBw==	74033626-4cde-4782-be79-e18d2ac8e0fe	BRCA2	37.03	0.0	0.12	0.699	14	PEGSLVFHEKAWNAYPYCRTIVTNEYM	PEGSLVFHEKAWNWYPYCRTIVTNEYM
PJVqKF5q1H2wGfwpjpr3/A==	74033626-4cde-4782-be79-e18d2ac8e0fe	BRCA2	98.68	0.0	0.781	0.718	14	PGLYGSVIVAGGNTLIQSFTDRLNREL	PGLYGSVIVAGGNRLIQSFTDRLNREL
AEeF3LVMZTrLpmJ17B071A==	74033626-4cde-4782-be79-e18d2ac8e0fe	BRCA2	80.48	0.0	0.611	0.77	14	FSLVGKRAISTSVCVRAHESVVKSEDF	FSLVGKRAISTSVNVRAHESVVKSEDF
SsvIXBP/9ICakrVJr+5DBQ==	74033626-4cde-4782-be79-e18d2ac8e0fe	BRCA2	41.08	0.0	0.719	0.353	14	EELEDSFFRLREDHMLVKELSWKQQDE	EELEDSFFRLREDNMLVKELSWKQQDE
+4z7/vE9KVSLfR7XWCQC5w==	74033626-4cde-4782-be79-e18d2ac8e0fe	BRCA2	63.46	0.0	0.166	0.22	14	EGVLAADKKDWKGALDAFSAVQDPHSR	EGVLAADKKDWKGWLDAFSAVQDPHSR
rko+PdK05/YydqwYHT7XxQ==	74033626-4cde-4782-be79-e18d2ac8e0fe	BRCA2	34.38	0.0	0.353	0.912	14	IPLGHMLTQKIAYQIASGLAYLHKKNI	IPLGHMLTQKIAYEIASGLAYLHKKNI
/tnHdmyaMibXNxFShCW9ow==	74033626-4cde-4782-be79-e18d2ac8e0fe	BRCA2	66.42	0.0	0.436	0.194	14	PFGQIEECRILRGPDGLSRGCAFVTFS	PFGQIEECRILRGWDGLSRGCAFVTFS
WiVErC2oUv+uBXZOfNhBtQ==	74033626-4cde-4782-be79-e18d2ac8e0fe	BRCA2	53.58	0.0	0.578	0.517	14	KARDVPLEMAEPPDPPQELPIPSSEPP	KARDVPLEMAEPPLPPQELPIPSSEPP
NYsXcc1usFohXy57pTqxgg==	74033626-4cde-4782-be79-e18d2ac8e0fe	BRCA2	77.67	0.0	0.697	0.664	14	LKEAPSAPVILPSAEQTTLEASSTPAD	LKEAPSAPVILPSMEQTTLEASSTPAD
2il63m1Rg7KyQwrPD58NTw==	1b69edea-82b8-4b42-91c9-0d78234d7758	BRCA2	29.15	0.0	0.364	0.202	14	EEKDAIEELVKYQLEKTQRFLKERHID	EEKDAIEELVKYQTEKTQRFLKERHID
Yefhnk1iUoSa77QaNuazSg==	1b69edea-82b8-4b42-91c9-0d78234d7758	BRCA2	78.42	0.0	0.764	0.317	14	SDDVPIRDYRIDEKNFVVVMVTKTKAG	SDDVPIRDYRIDECNFVVVMVTKTKAG
VEt6Ts2Myvp82L/2UHBIMg==	1b69edea-82b8-4b42-91c9-0d78234d7758	BRCA2	87.76	0.0	0.298	0.442	14	KQIGVKNVKLSEYEMSIAAHLVDPLNM	KQIGVKNVKLSEYQMSIAAHLVDPLNM
CsExA4bu69+2OakVrWRPRA==	1b69edea-82b8-4b42-91c9-0d78234d7758	BRCA2	18.32	0.0	0.743	0.529	14	ASPQETRQHESKPDEWRLSSSADANGN	ASPQETRQHESKPPEWRLSSSADANGN
/JWSlEs9BBTsHNGY4W/Qxg==	1b69edea-82b8-4b42-91c9-0d78234d7758	BRCA2	94.76	0.0	0.721	0.729	14	NSAETLQEHETDANREGPEVQEPEKRP	NSAETLQEHETDADREGPEVQEPEKRP
9z7T3ksi6f4X+HNY8l2BHw==	1b69edea-82b8-4b42-91c9-0d78234d7758	BRCA2	47.73	0.0	0.664	0.161	14	QFKIKRHTPLSKLMKAYCERQGLSMRQ	QFKIKRHTPLSKLDKAYCERQGLSMRQ
BTw7vWnTz4HVB3kg+IVyFQ==	1b69edea-82b8-4b42-91c9-0d78234d7758	BRCA2	53.81	0.0	0.935	0.876	14	EKMFLHVKGEIHLGRFVMRNRDVVLTT	EKMFLHVKGEIHLDRFVMRNRDVVLTT
d628KmBHnH6H9ePcStlTEA==	1b69edea-82b8-4b42-91c9-0d78234d7758	BRCA2	47.47	0.0	0.982	0.225	14	QSGGILLSLVANVLMVLSTATNYWTRQ	QSGGILLSLVANVTMVLSTATNYWTRQ
gVwSfETNo4j0deg4bk/H6w==	1b69edea-82b8-4b42-91c9-0d78234d7758	BRCA2	11.83	0.0	0.193	0.593	14	LLSVARKERGWRTVFPSREFWHRLRVI	LLSVARKERGWRTRFPSREFWHRLRVI
ziw2RkaxIz5iEOiXj7ONjg==	1b69edea-82b8-4b42-91c9-0d78234d7758	BRCA2	16.54	0.0	0.833	0.684	14	APSSRRTTLCGTLDYLPPEMIEGRMHD	APSSRRTTLCGTLPYLPPEMIEGRMHD
/ZHyMRV2/RdvjacHt8JLug==	27cda3c6-10e3-4c29-8b67-fc20426f6bc1	BRCA2	75.61	0.0	0.885	0.416	14	RVFLERTERRRYAHEYFHNAIFTPDEN	RVFLERTERRRYAVEYFHNAIFTPDEN
nb8ZxJJkABA7vXVjv/rcsg==	27cda3c6-10e3-4c29-8b67-fc20426f6bc1	BRCA2	79.79	0.0	0.335	0.68	14	HKKYQHIHQKSFSCPEPACGKSFNFKK	HKKYQHIHQKSFSAPEPACGKSFNFKK
dqV24y7m3ilui0cF53d3lw==	27cda3c6-10e3-4c29-8b67-fc20426f6bc1	BRCA2	59.36	0.0	0.392	0.574	14	RHVHLECRLQLWWCGGAPDSSIPDDHQ	RHVHLECRLQLWWEGGAPDSSIPDDHQ
o4zoGWsON780mrmxswjzqQ==	27cda3c6-10e3-4c29-8b67-fc20426f6bc1	BRCA2	95.47	0.0	0.515	0.242	14	DRGFDGLPGLPGEKGHRGDTGAQGLPG	DRGFDGLPGLPGEFGHRGDTGAQGLPG
c+fOw/R4MHwb+/vEGI3a4w==	27cda3c6-10e3-4c29-8b67-fc20426f6bc1	BRCA2	91.27	0.0	0.117	0.479	14	GSDKAKAKIACLAGIVFILSGLCSMTG	GSDKAKAKIACLAEIVFILSGLCSMTG
D+nCEWMJZHgpO1feNlKq1g==	27cda3c6-10e3-4c29-8b67-fc20426f6bc1	BRCA2	16.56	0.0	0.67	0.375	14	QWAAVATFLYAEIGLILIFCLPFIPPQ	QWAAVATFLYAEILLILIFCLPFIPPQ
+0bJoyfzQ9xnp+uA3NDxLA==	27cda3c6-10e3-4c29-8b67-fc20426f6bc1	BRCA2	84.15	0.0	0.819	0.77	14	AIWNRDAEEDMPQRVVLLQRSQTTTER	AIWNRDAEEDMPQYVVLLQRSQTTTER
NnCxA4JVT1Qnt8P4j4+LnQ==	27cda3c6-10e3-4c29-8b67-fc20426f6bc1	BRCA2	26.47	0.0	0.691	0.91	14	VILSVIFMNGNKASEAVIWEVLRKLGL	VILSVIFMNGNKAVEAVIWEVLRKLGL
6YfDUKUYq7xkT8VmE/q9qA==	27cda3c6-10e3-4c29-8b67-fc20426f6bc1	BRCA2	44.16	0.0	0.246	0.581	14	GMYEQLKGEWNRKSPNLSKCGEELGRL	GMYEQLKGEWNRKHPNLSKCGEELGRL
UG5I+CvKhaCpxaSrIzUQ5w==	27cda3c6-10e3-4c29-8b67-fc20426f6bc1	BRCA2	64.78	0.0	0.633	0.331	14	LAIGFFPGSSQGCDAFLRHKMTLISPI	LAIGFFPGSSQGCEAFLRHKMTLISPI
dLp5X2IJSNuYfFKXhyNttg==	c192558d-cdaf-4b86-9c5a-37591992b673	BRCA2	55.26	0.0	0.85	0.674	14	QGWLSSWLPTWRPTSMSQLKNVEARIL	QGWLSSWLPTWRPDSMSQLKNVEARIL
WY67DT+q+cGA5Tu+JKGnYg==	c192558d-cdaf-4b86-9c5a-37591992b673	BRCA2	20.5	0.0	0.813	0.826	14	SAYTSKILPPEKEGGLPRQVGNKTECA	SAYTSKILPPEKEEGLPRQVGNKTECA
MgIQKziPeMiS8ybvy9ZMVA==	c192558d-cdaf-4b86-9c5a-37591992b673	BRCA2	27.92	0.0	0.723	0.518	14	TQVKESLSSYWESAKTAAQNLYEKTYL	TQVKESLSSYWESHKTAAQNLYEKTYL
d/LqCpdf2RaBisaJTHe3Vw==	c192558d-cdaf-4b86-9c5a-37591992b673	BRCA2	86.66	0.0	0.196	0.374	14	EGKATKPARNALEKLTAAVRSMEELYS	EGKATKPARNALECLTAAVRSMEELYS
ADbT84yyqT69Yh4ANMRXaQ==	c192558d-cdaf-4b86-9c5a-37591992b673	BRCA2	92.64	0.0	0.965	0.83	14	SISNGFFECERRCDADPCCTGFGFLNV	SISNGFFECERRCFADPCCTGFGFLNV
fbtpirHY0vSutalwTSpW0Q==	c192558d-cdaf-4b86-9c5a-37591992b673	BRCA2	32.91	0.0	0.184	0.806	14	XMKRASSLNVLNVGGKAAEDRFQERNN	XMKRASSLNVLNVKGKAAEDRFQERNN
ZSXflMAMYiLpGybMKseC/A==	c192558d-cdaf-4b86-9c5a-37591992b673	BRCA2	50.52	0.0	0.568	0.552	14	GKRLRRVACTCPNCKEGGGRGTNLGKK	GKRLRRVACTCPNGKEGGGRGTNLGKK
V2RFeGpfkdEO8FMSXTnhbg==	c192558d-cdaf-4b86-9c5a-37591992b673	BRCA2	19.72	0.0	0.904	0.209	14	QIPNGSRSHEPLSVDSVSNNLAADAVG	QIPNGSRSHEPLSDDSVSNNLAADAVG
5aXAakVZw5ppyHQOaf/D8w==	c192558d-cdaf-4b86-9c5a-37591992b673	BRCA2	74.38	0.0	0.41	0.657	14	IFLTKKGRQVCAKPSGPGVQDCMKKLK	IFLTKKGRQVCAKASGPGVQDCMKKLK
ZhlBA8HAMokT8Tq9qRS1jg==	c192558d-cdaf-4b86-9c5a-37591992b673	BRCA2	61.73	0.0	0.835	0.477	14	VLLALSGQARGDPRAISAQEAHAPGRL	VLLALSGQARGDPDAISAQEAHAPGRL
